Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: JAMA Oncol. 2017 Apr 1;3(4):493–500. doi: 10.1001/jamaoncol.2016.5116

Table 3.

Multivariable Analysis of Predictors of HCC Recurrence and Creation of the RETREAT Score

Predictor Multivariable HR (95% CI) P Value β Coefficient RETREAT Pointsa
AFP at LT, ng/mL
 0–20 1 [Reference] NA NA 0
 21–99 1.80 (1.05–3.10) .03 0.59 1
 100–999 2.56 (1.42–4.62) .002 0.94 2
 ≥1000 4.45 (1.98–10.00) <.001 1.49 3
Microvascular invasion 3.80 (2.23–6.47) <.001 1.34 2
Largest viable tumor diameter (cm) plus No. of viable tumorsb
 0 1 [Reference] NA NA 0
 1.1–4.9 1.58 (0.73–3.39) .25 0.45 1
 5.0–9.9 2.69 (1.24–5.83) .01 0.99 2
 ≥10 6.75 (2.55–17.88) <.001 1.91 3

Abbreviations: AFP, α-fetoprotein level; HCC, hepatocellular carcinoma; HR, hazard ratio; LT, liver transplantation; NA, not applicable; RETREAT, risk estimation of tumor recurrence after transplant.

a

The RETREAT score is obtained by adding the total number of points scored in each of the 3 variables (range, 0–8). RETREAT score = 0 if a patient has an AFP of 0 to 20 ng/mL at LT, no microvascular invasion, and no viable tumor in the explant.

b

For example, if there are 3 lesions on explant, 2 viable lesions measuring 4 cm and 3 cm and a single completely necrotic lesion measuring 5 cm, the completely necrotic lesion is not counted, and the sum of the largest diameter of viable tumor (cm) and number of viable tumors would be 6 (4 = diameter of the largest lesion + 2 = No. of viable tumors). Explant largest viable tumor diameter + No. = 0 if no viable tumor is identified.